Zwarthoff EC - Search Results

1

DNA methylation-based biomarkers in bladder cancer.

Kandimalla R, van Tilborg AA, Zwarthoff EC. Kandimalla R, et al. Among authors: zwarthoff ec. Nat Rev Urol. 2013 Jun;10(6):327-35. doi: 10.1038/nrurol.2013.89. Epub 2013 Apr 30. Nat Rev Urol. 2013. PMID: 23628807 Review.

2

Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder.

Van Tilborg AA, Hekman AC, Vissers KJ, van der Kwast TH, Zwarthoff EC. Van Tilborg AA, et al. Among authors: zwarthoff ec. Int J Cancer. 1998 Jan 5;75(1):9-14. doi: 10.1002/(sici)1097-0215(19980105)75:1<9::aid-ijc2>3.0.co;2-1. Int J Cancer. 1998. PMID: 9426683

3

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.

van Tilborg AA, Groenfeld LE, van der Kwast TH, Zwarthoff EC. van Tilborg AA, et al. Among authors: zwarthoff ec. Br J Cancer. 1999 May;80(3-4):489-94. doi: 10.1038/sj.bjc.6690383. Br J Cancer. 1999. PMID: 10408858 Free PMC article.

4

Molecular evolution of multiple recurrent cancers of the bladder.

van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, van der Kwast TH, Zwarthoff EC. van Tilborg AA, et al. Among authors: zwarthoff ec. Hum Mol Genet. 2000 Dec 12;9(20):2973-80. doi: 10.1093/hmg/9.20.2973. Hum Mol Genet. 2000. PMID: 11115841

5

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.

van Rhijn BW, Lurkin I, Radvanyi F, Kirkels WJ, van der Kwast TH, Zwarthoff EC. van Rhijn BW, et al. Among authors: zwarthoff ec. Cancer Res. 2001 Feb 15;61(4):1265-8. Cancer Res. 2001. PMID: 11245416

6

The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.

van Tilborg AA, de Vries A, Zwarthoff EC. van Tilborg AA, et al. Among authors: zwarthoff ec. J Pathol. 2001 May;194(1):76-80. doi: 10.1002/path.860. J Pathol. 2001. PMID: 11329144

7

NF2 status of meningiomas is associated with tumour localization and histology.

Kros J, de Greve K, van Tilborg A, Hop W, Pieterman H, Avezaat C, Lekanne Dit Deprez R, Zwarthoff E. Kros J, et al. J Pathol. 2001 Jul;194(3):367-72. doi: 10.1002/path.909. J Pathol. 2001. PMID: 11439370

8

Truncated NF2 proteins are not detected in meningiomas and schwannomas.

Den Bakker MA, van Tilborg AA, Kros JM, Zwarthoff EC. Den Bakker MA, et al. Among authors: zwarthoff ec. Neuropathology. 2001 Sep;21(3):168-73. doi: 10.1046/j.1440-1789.2001.00394.x. Neuropathology. 2001. PMID: 11666013

9

The random development of LOH on chromosome 9q in superficial bladder cancers.

van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, Zwarthoff EC. van Tilborg AA, et al. Among authors: zwarthoff ec. J Pathol. 2002 Nov;198(3):352-8. doi: 10.1002/path.1215. J Pathol. 2002. PMID: 12375268

10

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.

van Rhijn BW, van Tilborg AA, Lurkin I, Bonaventure J, de Vries A, Thiery JP, van der Kwast TH, Zwarthoff EC, Radvanyi F. van Rhijn BW, et al. Among authors: zwarthoff ec. Eur J Hum Genet. 2002 Dec;10(12):819-24. doi: 10.1038/sj.ejhg.5200883. Eur J Hum Genet. 2002. PMID: 12461689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters